To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 4/15 cls
Biogen Idec Inc. (NASDAQ:BIIB) Jefferies Thomas Wei Price target Buy 13% $82.96
Stifel Nicolaus Weisel Maged Shenouda Upgrade Hold (from sell)
Wei raised his target to $87 from $83 after Biogen Idec reported

Read the full 677 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers